The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model

European Journal of Pharmacology

Volumn 650, Issue 2-3, 2011, Pages 694-702

  Valsecchi, Anna Elisa ^a   Franchi, Silvia ^a   Panerai, Alberto Emilio ^a   Rossi, Alice ^a   Sacerdote, Paola ^a   Colleoni, Mariapia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytokines; Diabetes; Genistein; Nerve growth factor; Neuropathy; Oxidative stress

Indexed keywords

CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENISTEIN; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID PEROXIDE; MALONALDEHYDE; NERVE GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENZYME ACTIVITY; HYPERGLYCEMIA; INFLAMMATION; MALE; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SCIATIC NERVE; VASCULAR DISEASE; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AORTA, THORACIC; BRAIN; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GENISTEIN; HYPERALGESIA; HYPERGLYCEMIA; INFLAMMATION; LIVER; MALE; MICE; MICE, INBRED C57BL; NERVE GROWTH FACTORS; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SCIATIC NERVE; SUPEROXIDE DISMUTASE;

EID: 78651064824     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.060     Document Type: Article

References (59)

1. S.J. Bhathena, and M.T. Velasquez Beneficial role of dietary phytoestrogens in obesity and diabetes Am. J. Clin. Nutr. 76 2002 1191 1201
2. N.E. Cameron, S.E. Eaton, M.A. Cotter, and S. Tesfaye Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy Diabetologia 44 2001 1973 1988
3. A. Canta, A. Chiorazzi, C. Meregalli, V. Carozzi, N. Oggioni, G. Lauria, R. Lombardi, R. Bianchi, C. Porretta-Serapiglia, and G. Cavaletti Continuous buprenorphine delivery effect in streptozotocin-induced painful diabetic neuropathy in rats J. Pain 10 2009 961 968
4. M.C. Carrillo, S. Kanai, G.O. Ivy, and K. Kitani Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats Biochem. Pharmacol. 44 1992 2185 2189
5. S. Celik, and S. Erdogan Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats Mol. Cell. Biochem. 312 2008 39 46
6. M. Colleoni, and P. Sacerdote Murine models of human neuropathic pain Biochim. Biophys. Acta 1802 2010 924 933
7. F. Comelli, I. Bettoni, M. Colleoni, G. Giagnoni, and B. Costa Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress Phytother. Res. 23 2009 1678 1684
8. G. Conti, E. Scarpini, P. Baron, S. Livraghi, M. Tiriticchio, R. Bianchi, C. Vedeler, and G. Scarlato Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-1β and p75NTR J. Neurol. Sci. 195 2002 35 40
9. B. Costa, A.E. Trovato, F. Comelli, G. Giagnoni, and M. Colleoni The non-psychoactive cannabis constituent cannabidiol is an orally active therapeutic agent in rat chronic inflammatory and neuropathic pain Eur. J. Pharmacol. 556 2007 75 83
10. C. Courteix, A. Eschalier, and J. Lavarenne Streptozotocin-induced diabetic rats: behavioural evidence for a model of chronic pain Pain 53 1993 81 88
11. R. Dringen, P.G. Pawlowski, and J. Hirrlinger Peroxide detoxification by brain cells J. Neurosci. Res. 79 2005 157 165
12. A.J. Dugas, J. Castaeda-Acosta, G.C. Bonin, K.L. Price, N.H. Fisher, and G.W. Winston Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships J. Nat. Prod. 63 2000 327 331
13. V. Faradji, and J. Sotelo Low serum levels of nerve growth factor in diabetic neuropathy Acta Neurol. Scand. 1 1990 402 406
14. C. Feillet-Coudray, E. Rock, C. Coudray, K. Grzelkowska, V. Azais-Braesco, D. Dardevet, and A. Mazur Lipid peroxidation and antioxidant status in experimental diabetes Clin. Chim. Acta 284 1999 31 43
15. G.F. Gaetani, S. Galiano, L. Canepa, A.M. Ferraris, and H.N. Kirkman Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes Blood 73 1989 334 339
16. M.B. Gomes, L.J. Piccirillo, V.G. Nogueira, and H.J. Matos Acute-phase proteins among patients with type 1 diabetes Diab. Metab. 29 2003 405 411
17. J.M. Gonzalez-Clemente, D. Mauricio, C. Richart, M. Broch, A. Caixas, A. Megia, O. Gimenez-Palop, I. Simon, A. Martinez-Requelme, G. Gimenez-Perez, and J. Vendrell Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus Clin. Endocrinol. 63 2005 525 529
18. G. Gruden, G. Bruno, N. Chaturvedi EURODIAB Prospective Complication Study Group Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy Diabetes 57 2008 1966 1970
19. T.J. Guzik, R. Olszanecki, J. Sadowski, B. Kapelak, P. Rudzinski, A. Jopek, A. Kawczynska, N. Ryszawa, J. Loster, J. Jawien, M. Czesnikiewicz-Guzik, K.M. Channon, and R. Korbut Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels J. Physiol. Pharmacol. 56 2005 313 323
20. P.J. Hissin, and R. Hilf A fluorimetric method for determination of oxidized and reduced glutathione in tissues Anal. Biochem. 74 1976 214 226
21. Y.M.J.J. Hoybergs, and T.F. Meert The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy Neurosci. Lett. 417 2007 149 154
22. I. Idris, and R. Donnelly Protein kinase C beta inhibition: a novel therapeutic strategy for diabetic microangiopathy Diab. Vasc. Dis. Res. 3 2006 172 178
23. T. Ikeda, Y. Ishida, R. Naono, R. Takeda, H. Abe, T. Nakamura, and T. Nishimori Effects of intrathecal administration of newer antidepressant on mechanical allodynia in rat models of neuropathic pain Neurosci. Res. 63 2009 42 46
24. C.G. Jolivalt, L.M. Mizisin, A. Nelson, J.M. Cunha, K.M. Ramos, D. Bonke, and N.A. Calcutt B vitamins alleviate indices of neuropathic pain in diabetes rats Eur. J. Pharmacol. 612 2009 41 47
25. H. Kamiya, W. Zhang, and A.A. Sima C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes Ann. Neurol. 56 2004 827 835
26. S. Kiguchi, T. Imamura, K. Ichikawa, and M. Kojima Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy Clin. Exp. Pharmacol. Physiol. 31 2004 57 64
27. A. Kuhad, and K. Chopra Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy Neuropharmacology 57 2009 456 462
28. I. Kyoraku, K. Shiomi, K. Kangawa, and M. Nakazato Ghrelin reverses experimental diabetic neuropathy in mice Biochem. Biophys. Res. Commun. 389 2009 405 408
29. J.M. Lawler, W. Song, and S.R. Demaree Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle Free Radic. Biol. Med. 35 2003 9 16
30. P.A. Low, K.K. Nickander, and H.J. Tritschler The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy Diabetes 46 1997 S38 S42
31. P. Manna, J. Das, J. Ghosh, and P.C. Sil Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IκBα/NF-κB, MAPKs, and mitochondria-dependent pathways: prophylactic role of arjunolic acid Free Radic. Biol. Med. 48 2010 1465 1484
32. M.F. McCarty Isoflavones made simple-Genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits Med. Hypotheses 66 2006 1093 1114
33. D.J. Moore, J.M. Gregory, Y.A. Kumah-Crystal, and J.H. Simmons Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence Vasc. Health Risk Manag. 5 2009 1015 1031
34. M. Nagamatsu, K.K. Nickander, J.D. Schmelzer, A. Raya, D.A. Wittrock, H. Tritschler, and P.A. Low Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy Diab. Care 18 1995 1160 1167
35. I.G. Obrosova, L. Fathallah, and M.J. Stevens Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy Exp. Neurol. 172 2001 211 219
36. P. Palsamy, and S. Subramanian Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats Chem. Biol. Interact. 179 2009 356 362
37. L. Pari, and C. Sankaranarayanan Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats Life Sci. 85 2009 830 834
38. J. Park, S.S. Choe, A.H. Choi, K.H. Kim, M.J. Yoon, T. Suganami, Y. Ogawa, and J.B. Kim Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals Diabetes 55 2006 2939 2949
39. R. Pazdro, and J.R. Burgess The role of vitamin E and oxidative stress in diabetic complications Mech. Ageing Dev. 131 2010 276 286
40. D.A. Rees, and J.C. Alcolado Animal models of diabetes mellitus Diabet. Med. 22 2005 359 370
41. A. Rivero, C. Mora, M. Muros, J. Garcia, H. Herrera, and J.F. Navarro-Gonzalez Pathogenic perspectives for the role of inflammation in diabetic nephropathy Clin. Sci. (Lond.) 116 2009 479 492
42. A.K. Saini, H.A.S. Kumar, and S.S. Sharma Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy Eur. J. Pharmacol. 568 2007 164 172
43. H. Si, and D. Liu Phytochemical genistein in the regulation of vascular function: new insights Curr. Med. Chem. 14 2007 2581 2589
44. R.C.M. Siow, F.Y.L. Li, D.J. Rowlands, P. de Winter, and G.E. Mann Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defence genes Free Radic. Biol. Med. 42 2007 909 925
45. D.S. Skundric, and R.P. Lisak Role of neuropoietic cytokines in development and progression of diabetic polineuropathy: from glucose metabolism to neurodegeneration Exp. Diabesity Res. 4 2003 303 312
46. D.R. Tomlinson, P. Fernyhough, and L.T. Diemel Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors Diabetes 46 Suppl 2 1997 S43 S49
47. T. Tosaki, H. Kamiya, Y. Yasuda, K. Naruse, K. Kato, M. Kozakae, N. Nakamura, T. Shibata, Y. Hamada, E. Nakashima, Y. Oiso, and J. Nakamura Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons Exp. Neurol. 213 2008 381 387
48. C. Toth, A.M. Schmidt, U.I. Tuor, G. Francis, T. Foniok, V. Brussee, J. Kaur, S.F. Yan, J.A. Martinez, P.A. Barber, A. Buchan, and D.W. Zochodne Diabetes, leukoencephalopathy and rage Neurobiol. Dis. 23 2006 445 461
49. T. Valente, A. Gella, X. Fernandez-Busquets, M. Unzeta, and N. Durany Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus Neurobiol. Dis. 37 2010 67 76
50. A.E. Valsecchi, S. Franchi, A.E. Panerai, P. Sacerdote, A.E. Trovato, and M. Collleoni Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity J. Neurochem. 107 2008 230 240
51. M. Verdreng, I.M. Jonsson, R. Holmdahl, and A. Tarkowski Genistein as an anti-inflammatory agent Inflamm. Res. 52 2003 341 346
52. J. Vina, A. Lloret, S.L. Valles, C. Borras, M.-C. Badia, F.V. Pallardò, J. Sastre, and M.D. Alonso Effect of gender on mitochondrial toxicity of Alzheimer's Aβ peptide Antioxid. Redox Signal. 9 2007 1677 1690
53. A.I. Vinik, T.S. Park, K.B. Stansberry, and G.L. Pittinger Diabetic neuropathies Diabetologia 43 2000 957 973
54. Y. Wang, J.D. Schmelzer, A. Schmeichel, H. Iida, and P.A. Low Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy J. Neurol. Sci. 227 2004 101 107 (Pubitemid 39491132)
55. C.F. Wang, D.Q. Li, H.Y. Xue, and B. Hu Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats Brain Res. 2307 2010 158 165
56. S. Wu, and J. Ren Benfotiamine alleviates diabetic-induced cerebral oxidative damage independent of advanced of advanced glycation end-product, tissue factor and TNF-alpha Neurosci. Lett. 394 2006 158 162
57. H.R. Yilmaz, E. Uz, N. Yucel, I. Altuntas, and N. Ozcelik Protective effect of caffeic acid phenenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver J. Biochem. Mol. Toxicol. 18 2004 234 238
58. J.H. Zhao, Y. Arao, S.J. Sun, A. Kikuchi, and F. Kayama Oral administration of soy-derived genistein suppresses lipopolysaccharide-induced acute liver inflammation but does not induce thymic atrophy in the rat Life Sci. 78 2006 812 819
59. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110